Finance

Beta
Lists
CRDF:NASDAQ
Cardiff Oncology Inc
$1.52
-0.33%
(-0.0050) 1D
Jun 10, 11:06:23 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRDF...
Open
$1.51
High
$1.56
Low
$1.51
Mkt. cap
104.61M
Avg. vol.
1.35M
Volume
308.59K
52-wk high
$4.56
52-wk low
$1.35
EPS
-$0.67
Beta
1.36
Shares outstanding
68.37M
No. of employees
31
Open
$1.51
High
$1.56
Low
$1.51
Mkt. cap
104.61M
Avg. vol.
1.35M
Volume
308.59K
52-wk high
$4.56
52-wk low
$1.35
EPS
-$0.67
Beta
1.36
Shares outstanding
68.37M
No. of employees
31
Analyst outlook
Analyst Ratings
Based on 7 analysts giving stock ratings to CRDF in the past 3 months
Buy
Buy
4
Hold
3
Sell
0
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for CRDF in the last 3 months.
Highest
Current $1.52
$12.00 (+686.89%)
Average
$6.00 (+293.44%)
Lowest
$2.00 (+31.15%)
News stories
From sources across the web
About Cardiff Oncology Inc
CEOMark Erlander
Employees31
Founded1999
Headquarters-
SectorBiotechnology
Websitecardiffoncology.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
121.00K
120.00K
243.00K
41.00K
Cost of goods sold
11.58M
8.20M
5.08M
6.76M
Cost of revenue
11.58M
8.20M
5.08M
6.76M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.32M
3.90M
3.00M
6.13M
Operating expense
3.32M
3.90M
3.00M
6.13M
Total operating expenses
14.90M
12.09M
8.07M
12.89M
Operating income
-14.78M
-11.97M
-7.83M
-12.85M
Other non operating income
-1.00K
-
-1.00K
-1.00K
EBT including unusual items
-13.94M
-11.26M
-7.22M
-12.34M
EBT excluding unusual items
-13.94M
-11.26M
-7.22M
-12.34M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-13.94M
-11.26M
-7.22M
-12.34M
Net profit margin
-11,523.14%
-9,381.67%
-2,969.55%
-30,109.76%
Earnings per share
-0.21
-0.17
-0.11
-0.18
Interest and investment income
835.00K
716.00K
612.00K
506.00K
Interest expense
-
-
-
-
Net interest expenses
835.00K
716.00K
612.00K
506.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-14.68M
-11.88M
-7.74M
-12.76M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer